The Product should not be used in case of hypersensitivity to pyrazolones.It is contraindicated to patients suffering form existing disturbances of blood cell formation.
Analgin passes the placental barrier, and should there fore be used during pregnancy, especially during the first 3 rnonths and the last 6 weeks, only after careful consideration of the indications. Analgin was considered to be unsafe in patients with acute porphyria.
Analgin produced an exacerbation of dyspnoea, cyanosis and respiratory arrest,
Agranulocytosis presumed to be due to Analgin Allergic skin reactions.
Administration: It may be given by intramuscular or intravenous injection in doses of
Precautions & Warning:
It contains Metamizole /Analgin which may cause agranulocytosts.
To be sold on prescription of registered medical practitioner only.